FactBook and Benchmarks
Highlights Reflecting More Than Ten Years of Growth and Impact
Total Number of Faculty
97%
2003: 61
2017: 120
Total Pharm.D. Enrollment
1%
2003: 598
2017: 605
Total M.S./Ph.D. Enrollment
44%
2003: 70
2017: 101
Space (Chapel Hill Campus)
92%
2005: 164,507 square feet
2017: 315,083 square feet
Total External Grants & Contracts Support
481%
2003: $6,565,996
2017: $38,154,834
U.S. News & World Report Rankings
6 spots
2003: No. 7
2017: No. 1
AACP Rankings in Grants and Contracts
Federal FY |
Grand Total |
*Rank |
| 2017 | $38,154,834 | N/A |
| 2016 | $36,342,302 | 2 |
| 2015 | $27,014,955 | 2 |
| 2014 | $20,926,094 | 3 |
| 2013 | $22,652,831 | 2 |
| 2012 | $27,730,713 | 2 |
| 2011 | $25,235,613 | 2 |
| 2010 | $24,327,408 | 3 |
| 2009 | $24,924,364 | 4 |
| 2008 | $24,471,630 | 2 |
| 2007 | $13,270,078 | 6 |
| 2006 | $12,350,021 | 6 |
| 2005 | $6,905,496 | 15 |
| 2004 | $6,566,008 | 15 |
| 2003 | $4,278,677 | 24 |
| 2002 | $3,790,106 | 21 |
*Based on grand total.
U.S. News & World Report Rankings
In 2016, the UNC Eshelman School of Pharmacy was ranked the #1 pharmacy school in the nation when U.S. News & World Report published its list of the 2017 Best Graduate Schools. The ranking included pharmacy schools with doctor of pharmacy programs accredited by the Accreditation Council for Pharmacy Education. The rankings were based on the results of surveys sent to deans, other administrators, and/or faculty at accredited degree programs or schools in the fall of 2015.
In 2016, the University of North Carolina at Chapel Hill was also ranked second among best global universities for pharmacology and toxicology by U.S. News & World Report.
Best Graduate School Rankings
Rank |
College Name |
Score |
| 1 | University of North Carolina – Chapel Hill Chapel Hill, NC |
4.7 |
| 2 | University of Minnesota Minneapolis, MN |
4.5 |
| 3 | University of California – San Francisco San Francisco, CA |
4.4 |
| 3 | University of Michigan – Ann Arbor Ann Arbor, MI |
4.4 |
| 3 | University of Texas – Austin Austin, TX |
4.4 |
| 6 | Ohio State University Columbus, OH |
4.2 |
| 6 | University of Illinois – Chicago Chicago, IL |
4.2 |
| 6 | University of Kentucky Lexington, KY |
4.2 |
| 9 | Purdue University West Lafayette, IN |
4.1 |
| 9 | University of Florida Gainesville, FL |
4.1 |
| 9 | University of Maryland – Baltimore Baltimore, MD |
4.1 |
| 9 | University of Pittsburgh Pittsburgh, PA |
4.1 |
| 9 | University of Southern California Los Angeles, CA |
4.1 |
| 9 | University of Washington Seattle, WA |
4.1 |
| 9 | University of Wisconsin – Madison Madison, WI |
4.1 |
Previous U.S. News Rankings (1997-2016)
Year |
Ranking |
| 2016 | 1 |
| 2012 | 2 |
| 2008 | 2 |
| 2004 | 3 |
| 1997 | 7* |
*Tied with five other schools
QS World University Rankings by Subject
Top Universities for Pharmacy and Pharmacology
QS ranks the world’s top universities in 36 individual subjects, based on academic reputation, employer reputation and research impact (full methodology here).
UNC Eshelman School of Pharmacy Ranking
Incoming Student Characteristics
Incoming Year |
# of Enrolled Students |
Average Incoming GPA |
Average PCAT |
| 2018 | 145 | 3.5 | 88 |
| 2017 | 154 | 3.5 | 87 |
| 2016 | 141 | 3.5 | 88 |
| 2015 | 154 | 3.5 | 88 |
| 2014 | 162 | 3.5 | 87 |
| 2013 | 162 | 3.5 | 86 |
| 2012 | 180 | 3.5 | 83 |
| 2011 | 165 | 3.5 | 80 |
| 2010 | 153 | 3.4 | 82 |
| 2009 | 153 | 3.5 | 83 |
| 2008 | 151 | 3.5 | 85 |
| 2007 | 155 | 3.5 | 84 |
Incoming Year |
Male (%) |
Female (%) |
North Carolina Residents (%) |
Non-NC Residents (%) |
| 2018 | 33 | 67 | 43 | 57 |
| 2017 | 32 | 68 | 59 | 41 |
| 2016 | 30 | 70 | 51 | 49 |
| 2015 | 32 | 68 | 60 | 40 |
| 2014 | 35 | 65 | 62 | 38 |
| 2013 | 39 | 61 | 64 | 36 |
| 2012 | 33 | 67 | 72 | 28 |
| 2011 | 31 | 68 | 78 | 22 |
| 2010 | 35 | 62 | 77 | 23 |
| 2009 | 30 | 70 | 72 | 28 |
| 2008 | 35 | 65 | 86 | 14 |
| 2007 | 30 | 70 | 84 | 16 |
Incoming Year |
White (%) |
Asian (%) |
African American or Black (%) |
Native American or Alaska Native (%) |
Two or more races* (%) |
Unknown/ Other (%) |
URM** (%) |
Hispanic* (%) |
| 2018 | 62 | 24 | 10 | <1 | 2 | 1 | 17 | 5 |
| 2017 | 60 | 23 | 6 | <1 | 2 | 8 | 12 | 5 |
| 2016 | 61 | 27 | 8 | 0 | 4 | 0 | 12 | 4 |
| 2015 | 62 | 23 | 12 | 0 | 3 | 0 | 20 | 6 |
| 2014 | 65 | 20 | 5 | 0 | 6 | 4 | 8 | 1 |
| 2013 | 71 | 14 | 7 | 1 | 4 | 3 | 15 | 6 |
| 2012 | 62 | 19 | 5 | 1 | N/A | 8 | N/A | 4 |
| 2011 | 67 | 13 | 8 | 2 | N/A | 8 | N/A | 2 |
| 2010 | 68 | 17 | 8 | 0 | N/A | 7 | N/A | 0 |
| 2009 | 70 | 15 | 3 | 0 | N/A | 9 | N/A | 3 |
| 2008 | 69 | 15 | 7 | 0 | N/A | 7 | N/A | 2 |
| 2007 | 68 | 19 | 4 | 0 | N/A | 7 | N/A | 2 |
* Starting in 2013, Hispanic is measured as an ethnicity of any race (percentages of race categories may add up to more than 100).
Two or more races option was not provided prior to 2013.
** URM (Under-Represented Minorities) includes African American or Black, Native American or Alaska Native, Native Hawaiian or Pacific Islander, or Hispanic of any race.
Year |
Total # of Enrolled Students |
Chapel Hill |
Elizabeth City |
Asheville |
| 2018 | 580 | 492 | NA | 88 |
| 2017 | 605 | 502 | NA | 103 |
| 2016 | 608 | 511 | NA | 97 |
| 2015 | 646 | 548 | NA | 98 |
| 2014 | 656 | 568 | NA | 88 |
| 2013 | 643 | 554 | 28 | 61 |
| 2012 | 639 | 560 | 40 | 39 |
| 2011 | 669 | 614 | 38 | 17 |
| 2010 | 649 | 608 | 41 | NA |
| 2009 | 642 | 602 | 40 | NA |
| 2008 | 643 | 600 | 43 | NA |
| 2007 | 592 | 555 | 37 | NA |
| 2006 | 563 | 540 | 23 | NA |
| 2005 | 534 | 520 | 14 | NA |
| 2004 | 515 | 515 | NA | NA |
| 2003 | 505 | 505 | NA | NA |
Student Outcomes
Year |
Four-Year Graduation Rate (%) |
Delayed (%)* |
Dismissed (%) |
Withdrew (%) |
| 2018 | 96 | 2 | 0 | 2 |
| 2017 | 97 | 3 | <1 | 0 |
| 2016 | 96 | 2 | 0 | 2 |
| 2015 | 93 | 4 | 0 | 2 |
| 2014 | 92 | 5 | 3 | 1 |
| 2013 | 95 | 3 | <1 | <1 |
| 2012 | 92 | 3 | <1 | 4 |
| 2011 | 90 | 5 | 4 | <1 |
| 2010 | 95 | 2 | 0 | 3 |
| 2009 | 94 | 3 | 1 | 2 |
| 2008 | 97 | 2 | <1 | <1 |
2018: 4 students were delayed: 3 for medical reasons and 1 to meet the requirements of the PharmD/MPH dual degree program
2017: 8 students were delayed: 3 for academic reasons, 1 for medical reasons, 3 to meet the requirements of the PharmD/MPH dual degree program, and 1 to meet the requirements of the PharmD/MBA dual degree program
2016: 4 students were delayed: 1 for academic reasons, 2 for medical reasons, and 1 for other reason
2015: 7 students were delayed: 4 for academic reasons, 1 for medical reasons, and 2 for other reasons
2014: 7 students were delayed: 2 for academic reasons, 4 for medical reasons, and 1 to meet the requirements of the PharmD/MBA dual degree program
2013: 5 students were delayed: 3 for academic reasons, 1 for medical reasons, and 1 to meet the requirements of the PharmD/MBA dual degree program
2012: 5 students were delayed: 1 for academic reasons, 3 for medical reasons, and 1 to meet the requirements of the PharmD/MBA dual degree program
2011: 7 students were delayed: 5 for medical reasons, 2 for other reasons
2010: 4 students were delayed: 1 for academic reasons, 2 for medical reasons, and 1 for other reasons
2009: 4 students were delayed: 3 for academic reasons, 1 for other reason
2008: 2 students were delayed: 1 for academic reasons, 1 for medical reasons
Year |
NAPLEX First-Time (%) |
MPJE First-Time (%) |
| 2018 | 96* | 93.22 |
| 2017 | 94.04* | 90.48 |
| 2016 | 94.55* | 94.93 |
| 2015 | 97.26 | 98.52 |
| 2014 | 97.81 | 99.20 |
| 2013 | 100.00 | 96.06 |
| 2012 | 97.89 | 98.54 |
| 2011 | 97.86 | 100.00 |
| 2010 | 98.60 | 99.27 |
| 2009 | 99.32 | 98.52 |
| 2008 | 99.20 | 98.29 |
*NABP revised the NAPLEX format in 2016.
As of August 2018
Residencies |
rankings
88 (54%) |
| Health System | 31 |
| Managed Care | 3 |
| Community Residency | 8 |
| Other Specialty Residency | 3 |
| Ambulatory Care | 9 |
| Acute Care | 33 |
| Home/Long-term Care | 1 |
Community Pharmacy |
18 (11%) |
| Chain | 13 |
| Independent | 5 |
Fellowships |
15 (9%) |
Hospital |
2 (1%) |
Industry |
3 (1.5%) |
Nuclear |
1 (0.5%) |
Post Graduate Education |
1 (0.5%) |
Not yet accepted a position |
26 (16%) |
[/table_row]
[table-row]
No Response |
9 (5.5%) |
[/table_row]
38 percent of all graduates are practicing in North Carolina
83 percent of graduates who accepted pharmacy practice positions are practicing in North Carolina
41percent of graduates who accepted residencies/fellowships are practicing in North Carolina
*163 professional students surveyed
63% of students who matched with a residency did so with their first-choice program (88% first or second choice)
77% of students who secured a fellowship did so with their first-choice program (92% first or second choice)
Master’s Program in Pharmaceutical Sciences with a Specialization in Health-System Pharmacy Administration
Incoming Year |
# of Applicants |
# of Enrolled Students |
Average Incoming GPA |
| 2018 | 61 | 10 | 3.44 |
| 2017 | 67 | 9 | 3.74 |
| 2016 | 48 | 10 | 3.60 |
| 2015 | 53 | 8 | 3.60 |
| 2014 | 68 | 8 | 3.61 |
| 2013 | 40 | 7 | 3.55 |
| 2012 | 44 | 7 | 3.56 |
Incoming Year |
Male (%) |
Female (%) |
White (%) |
Other/Unknown (%) |
| 2018 | [row_column30[/row_column]70 | 70 | 30 | |
| 2017 | [row_column44[/row_column]56 | 67 | 33 | |
| 2016 | 60 | 40 | 60 | 40 |
| 2015 | 38 | 62 | 38 | 62 |
| 2014 | 50 | 50 | 88 | 12 |
| 2013 | 43 | 57 | 86 | 14 |
| 2012 | 43 | 57 | 71 | 29 |
PhD Programs
Incoming Year |
# of Applicants |
# of Enrolled Students |
Average Incoming GPA |
Average GRE Verbal Percentile |
Average GRE Quantitative Percentile |
Average TOEFL Total Composite Score (Non-U.S. Citizens) |
| 2018 | 214 | 16 | 3.58 | 70.5 | 70.5 | 102 |
| 2017 | 229 | 16 | 3.56 | 79 | 81 | 105 |
| 2016 | 217 | 11 | 3.75 | 70 | 84 | 102 |
| 2015 | 213 | 17 | 3.75 | 80 | 76 | NA |
| 2014 | 222 | 18 | 3.70 | 74 | 79 | NA |
| 2013 | 181 | 19 | 3.74 | 77 | 76 | 102 |
| 2012 | 150 | 21 | 3.75 | 80 | 82 | 103 |
Incoming Year |
Male (%) |
Female (%) |
White (%) |
Non-Resident Alien (%) |
Other/Unknown (%) |
| 2018 | 31 | 69 | 50 | ||
| 2017 | 44 | 56 | 63 | 19 | 18 |
| 2016 | 45 | 55 | 45 | 36 | 18 |
| 2015 | 71 | 29 | 76 | 12 | 12 |
| 2014 | 39 | 61 | 61 | 6 | 33 |
| 2013 | 33 | 67 | 47 | 21 | 32 |
| 2012 | 52 | 48 | 43 | 43 | 14 |
Incoming Year |
CBMC (%) |
DPMP (%) |
DPOP (%) |
DPET (%) |
| 2018 | 25 | 25 | 12 | 38 |
| 2017 | 31 | 38 | 13 | 19 |
| 2016 | 34 | 33 | 12 | 21 |
| 2015 | 35 | 24 | 18 | 24 |
| 2014 | 22 | 39 | 17 | 22 |
| 2013 | 26 | 26 | 26 | 22 |
| 2012 | 24 | 43 | 9 | 24 |
CBMC = Chemical Biology and Medicinal Chemistry
DPMP = Pharmacoengineering and Molecular Pharmaceutics
DPOP = Pharmaceutical Outcomes and Policy
DPET = Pharmacotherapy and Experimental Therapeutics
Year |
# of Enrolled Students |
| 2016 | 112 |
| 2015 | 104 |
| 2014 | 101 |
| 2013 | 100 |
| 2012 | 106 |
| 2011 | 109 |
| 2010 | 100 |
| 2009 | 96 |
| 2008 | 91 |
| 2007 | 88 |
| 2006 | 82 |
| 2005 | 80 |
| 2004 | 80 |
| 2003 | 70 |
Student Outcomes
Graduating Year |
Total |
Male |
Female |
Black or African American |
Hispanic or Latino |
White |
Other |
Unknown |
| 2018 | 16 | 6 | 4 | 1 | 1 | 7 | 0 | 1 |
| 2017 | 10 | 4 | 6 | 1 | 1 | 6 | 0 | 0 |
| 2016 | 12 | 6 | 6 | 1 | 0 | 9 | 2 | 0 |
| 2015 | 7 | 3 | 4 | 0 | 0 | 6 | 0 | 1 |
| 2014 | 9 | 4 | 5 | 0 | 1 | 5 | 3 | 0 |
| 2013 | 8 | 7 | 1 | 0 | 0 | 8 | 0 | 0 |
| 2012 | 5 | 4 | 1 | 0 | 0 | 3 | 2 | 0 |
| 2011 | 5 | 2 | 3 | 0 | 0 | 3 | 1 | 1 |
| 2010 | 4 | 3 | 1 | 1 | 0 | 2 | 1 | 0 |
| 2009 | 2 | 0 | 2 | 0 | 0 | 1 | 1 | 0 |
Graduating Year |
Total |
Male |
Female |
Black or African American |
Hispanic or Latino |
White |
Other |
Unknown |
| 2018 | 30 | 6 | 9 | 0 | 0 | 8 | 7 | 0 |
| 2017 | 15 | 6 | 9 | 0 | 0 | 9 | 5 | 1 |
| 2016 | 16 | 12 | 4 | 1 | 1 | 5 | 9 | 0 |
| 2015 | 8 | 5 | 3 | 1 | 0 | 6 | 1 | 0 |
| 2014 | 11 | 5 | 6 | 0 | 0 | 5 | 6 | 0 |
| 2013 | 24 | 13 | 11 | 0 | 1 | 11 | 12 | 0 |
| 2012 | 15 | 6 | 9 | 1 | 1 | 2 | 10 | 1 |
| 2011 | 23 | 11 | 12 | 2 | 1 | 10 | 10 | 0 |
| 2010 | 16 | 6 | 10 | 2 | 0 | 5 | 0 | 0 |
| 2009 | NA | NA | NA | NA | NA | NA | NA | NA |
Academia |
4 (25%) |
| Faculty | 2 |
| Postdoc | 2 |
| Student | 0 |
Industry |
7 (32%) |
Hospital/Health Care |
9 (41%) |
Government |
0 (0%) |
Other |
2 (0.09%) |
Academia |
7 (28%) |
| Faculty | 0 |
| Postdoc | 7 |
| Student | 0 |
Industry |
9 (36%) |
Hospital/Health Care |
6 (24%) |
Government |
3 (12%) |
Other |
0 (0%) |
Leadership
| Dhiren Thakker, Ph.D. | Interim Dean |
| Kim Brouwer, Pharm.D., Ph.D. | Associate Dean for Research and Graduate Education |
| Wendy Cox, Pharm.D. | Assistant Dean for Professional Education |
| Rowell Daniels, M.S. | Executive Associate Dean, Pharmacy Clinical Practice at Chapel Hill |
| Annie Hager-Blunk | Associate Dean for Advancement |
| Roy Hawke, PharmD, Ph.D. | Assistant Dean and Director of Graduate Studies |
| Leaf Huang, Ph.D. | Interim Chair, Division of Pharmacoengineering and Molecular Pharmaceutics |
| Michael Jay, Ph.D. | Executive Vice Dean and Chief Academic Officer |
| Pam Joyner, EdD, M.S., Pharm.D. | Executive Associate Dean for Professional Education |
| Angela Kashuba, Pharm.D. | Chair, Division of Pharmacotherapy and Experimental Therapeutics |
| David Lawrence, Ph.D. | Chair, Division of Chemical Biology and Medicinal Chemistry |
| A. Wayne Pittman, M.S., Pharm.D. | Associate Dean for Facilities Planning and Resource Analysis |
| Stephen Eckel, Pharm.D. | Interim Chair, Division of Practice Advancement and Clinical Education |
| Phil Rodgers, Pharm.D. | Assistant Dean of Pharmacy Practice Partnerships |
| Mollie Scott, Pharm.D. | Regional Associate Dean at Asheville |
| Betsy Sleath, Ph.D. | Chair, Division of Pharmaceutical Outcomes and Policy |
| Dhiren Thakker, Ph.D. | Associate Dean for Global Engagement and Director of Entrepreneurial Development |
| Alex Tropsha, Ph.D. | Associate Dean for Pharmacoinformatics and Data Science |
| Rick Wernoski, M.P.A. | Executive Vice Dean and Chief Operating Officer |
| Carla White | Assistant Dean for Innovative Leadership and Diversity |
| Chris Allen | Facilities |
| Steve Dedrick, M.S. | Continuing Education |
| Stan Parker, M.B.A. | Marketing & Communications |
| Roy Hawke, Ph.D. | Research and Graduate Education |
| Kim Hutter | Human Resources |
| Raj Kshatriya, M.B.A. | Research Administration |
| Dave Maldonado | Information Technology |
| Mary McClurg, Pharm.D., M.H.S. | Strategic Planning and Assessment |
| Matt Rivenbark, M.A. | Finance |
| Jason Martin | Educational Technology |
| Brad Wingo, M.Ed. | Student Affairs |
Employee Headcounts
Year |
Faculty |
Administrative Staff |
Research Staff |
Total |
| 2018 | 122 | 102 | 56 | 280 |
| 2017 | 120 | 89 | 77 | 286 |
| 2016 | 122 | 102 | 56 | 280 |
| 2015 | 106 | 76 | 49 | 231 |
| 2014 | 105 | 74 | 38 | 217 |
| 2013 | 106 | 72 | 34 | 212 |
| 2012 | 101 | 64 | 38 | 203 |
| 2011 | 98 | 60 | 29 | 189 |
| 2010 | 90 | 58 | 30 | 172 |
| 2009 | 95 | 60 | 34 | 189 |
| 2008 | 95 | 59 | 29 | 183 |
| 2007 | 75 | 52 | 24 | 151 |
| 2006 | 71 | 51 | 20 | 142 |
| 2005 | 62 | 45 | 8 | 115 |
| 2004 | 62 | 42 | 9 | 113 |
| 2003 | 61 | 42 | 7 | 111 |
Faculty Rank and Track
As of Feb. 1, 2018
Rank |
Total |
| Distinguished Professor | 15 |
| Professor | 7 |
| Associate Professor | 17 |
| Assistant Professor | 19 |
| Clinical Professor | 5 |
| Clinical Associate Professor | 10 |
| Clinical Assistant Professor | 12 |
| Clinical Instructor | 1 |
| Research Professor | 5 |
| Research Associate Professor | 10 |
| Research Assistant Professor | 19 |
| Professor of Practice | 2 |
Total: 122
Track |
Total |
| Tenure | 55 |
| Clinical | 28 |
| Research | 35 |
| Professor of Practice | 2 |
Total: 120
| Jeff Aube, Ph.D. | Fred Eshelman Distinguished Professor |
| Robert A. Blouin, Pharm.D. | Vaughn & Nancy Bryson Distinguished Professor |
| Kim Brouwer, Pharm.D., Ph.D. | William R. Kenan Jr. Distinguished Professor |
| Leaf Huang, Ph.D. | Fred Eshelman Distinguished Professor |
| David Lawrence, Ph.D. | Fred Eshelman Distinguished Professor |
| K.H. Lee, Ph.D. | Kenan Distinguished Professor of Medicinal Chemistry |
| Jian Liu, Ph.D. | John & Deborah McNeill, Jr. Distinguished Professor |
| Xiao Xiao, Ph.D. | Fred Eshelman Distinguished Professor of Gene Therapy |
| Stephen Frye, Ph.D. | Fred Eshelman Distinguished Professor |
| Michael Jay, Ph.D. | Fred Eshelman Distinguished Professor |
| Sasha Kabanov, Ph.D. | Mescal S. Ferguson Distinguished Professor |
| Angela Kashuba, Pharm.D. | John A. McNeill Jr. Distinguished Professor |
| Betsy Sleath, Ph.D. | George H. Cocolas Distinguished Professor |
| Denise Rhoney, Pharm.D. | Ron and Nancy McFarlane Distinguished Professor |
| Alex Tropsha, Ph.D. | K.H. Lee Distinguished Professor |
Postdoc Fellows by Division
As of March 1, 2017
Division |
Total |
| CBMC | 28 |
| DPET | 32 |
| DPMP | 16 |
| DPOP | 2 |
| PACE | 15 |
| School Support | 4 |
Total: 97
Read the Annual Faculty Productivity Report, 2016
Pharmacy Alumni Association
The UNC Eshelman School of Pharmacy Alumni Association was established in 1980 to support alumni of the UNC Eshelman School of Pharmacy. We are a service organization of the School, and we welcome all alumni as members.
Mission
The UNC Eshelman School of Pharmacy Alumni Association strives to connect and engage alumni, students, and faculty through social, educational, and professional activities. It is dedicated to advancing the School and pharmacy profession.
Objectives
- Stimulate relationships between the School and its graduates and promote fellowship among alumni.
- Serve as School ambassadors by encouraging outstanding prospective students to consider pharmacy careers and mentoring current students.
- Recognize and celebrate the accomplishments of alumni who contribute to the profession and enhance the School’s reputation.
- Encourage fellow alumni and professionals to support pharmacy and pharmaceutical sciences education and research by making personal financial commitments to the School.
- Participate and engage in the planning and execution of programs and projects that advance the School and fulfill its strategic plan.
Where are we? Alumni of the UNC Eshelman School of Pharmacy live in 49 states and all but two of the 100 North Carolina counties.
Alumni Quick Facts 2018
Total (degree bearing) Alumni: |
7,829 |
| Total in the USA and on military bases | 7,761 |
| Total in N.C. | 5,771 |
| Total number of N.C. counties | 98 |
| Total U.S. states represented | 50 and Washington D.C. |
| Total living outside of the U.S.* | 68 |
*Locations for international alumni include: Australia, Bermuda, Canada, China, Denmark, England, Finland, France, Ghana, Iceland, India, Ireland, Japan, Jordan, Lebanon, Peru, Portugal, Singapore, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Zaire
**Please note: the map represents data collected in November 2012
Ten-Year Totals
External Funding Support
(2004-13)
$188,434,112
Salary Recovery Dollars
(2005-14)
$17,085,829
Facilities
(Chapel Hill Campus)
315,083 sq. ft.
Patents
(2005-14)
131
Startups
(2005-14)
15
Invention Disclosures
(2005-14)
161
This data represents NIH + CoI/PI funding and total funding from all sources, independently verified by the American Association of Colleges of Pharmacy (AACP).
Fiscal Year |
NIH + CoPI Funding |
Total Funding |
AACP Grant and Contract Ranking |
| 2016 | $36,358,931 | N/A | |
| 2015 | $27,014,955 | #2 | |
| 2014 | $20,926,094 | #3 | |
| 2013 | $18,856,550 | $22,652,829 | #2 |
| 2012 | $23,526,222 | $27,730,710 | #2 |
| 2011 | $21,010,624 | $25,235,610 | #2 |
| 2010 | $21,902,086 | $24,327,406 | #2 |
| 2009 | $22,935,797 | $24,924,362 | #2 |
| 2008 | $21,182,935 | $24,471,628 | #2 |
| 2007 | $10,372,364 | $13,270,072 | #6 |
| 2006 | $9,720,414 | $12,350,014 | #7 |
| 2005 | $6,905,485 | $6,905,485 | #11 |
| 2004 | $6,051,595 | $6,565,996 | #12 |
| 2003 | $3,913,665 | $4,278,656 | #21 |
| 2002 | $2,203,393 | $2,203,393 | #24 |
This data represents total salary recovery dollars for all principal investigators within the School.
Fiscal Year |
Total Salary Recovery Dollars |
| 2016 | $2,297,682 |
| 2015 | $1,848,943 |
| 2014 | $1,977,345 |
| 2013 | $2,105,705 |
| 2012 | $2,121,528 |
| 2011 | $2,047,935 |
| 2010 | $1,993,499 |
| 2009 | $2,105,998 |
| 2008 | $1,555,051 |
| 2007 | $1,379,488 |
| 2006 | $1,031,087 |
| 2005 | $768,192 |
| 2004 | $606,860 |
| 2003 | $200,000* |
| 2002 | $200,000* |
*Salary Recovery Dollar data is an estimate
This data represents the total indirect cost generated by the School.
Fiscal Year |
Total Indirect Cost Generated |
| 2016 | $957,875 |
| 2015 | $730,210 |
| 2014 | $4,883,298 |
| 2013 | $6,182,290 |
| 2012 | $5,755,229 |
| 2011 | $4,869,026 |
| 2010 | $4,890,265 |
| 2009 | $4,608,112 |
| 2008 | $4,061,711 |
| 2007 | $3,253,841 |
| 2006 | $2,461,049 |
| 2005 | $1,486,630 |
| 2004 | $1,319,551 |
| 2003 | $1,395,708 |
| 2002 | $1,095,840 |
This data represents the return of Salary Recovery Dollars and Facilities and Administrative (F&A) Dollars as a result of total investment spent on faculty hires and start-up packages.
Fiscal Year |
F&A Dollars |
Salary Recovery Dollars |
Total |
| 2016 | $957,875 | $2,297,682 | $3,255,557 |
| 2015 | $730,210 | $1,848,943 | $2,579,153 |
| 2014 | $4,883,298 | $1,977,345 | $6,860,643 |
| 2013 | $6,182,290 | $2,105,705 | $8,287,995 |
| 2012 | $5,755,229 | $2,121,528 | $7,876,757 |
| 2011 | $4,869,026 | $2,047,935 | $6,916,961 |
| 2010 | $4,890,265 | $1,993,499 | $6,883,764 |
| 2009 | $4,608,112 | $2,105,998 | $6,714,110 |
| 2008 | $4,061,711 | $1,555,051 | $5,616,762 |
| 2007 | $3,253,841 | $1,379,488 | $4,633,329 |
| 2006 | $2,461,049 | $1,031,087 | $3,492,136 |
| 2005 | $1,486,630 | $768,192 | $2,254,822 |
| 2004 | $1,319,551 | $606,860 | $1,926,411 |
| 2003 | $1,395,708 | $200,000* | $1,595,708 |
| 2002 | $1,095,840 | $200,000* | $1,295,840 |
*Salary Recovery Dollar data is an estimate
Chapel Hill
Building |
Total (gsf) |
School Occupied (gsf) |
Year Completed |
School Total (gsf) |
| Beard Hall | 74,589 | 74,589 | 1959 | 74,589 |
| Kerr Hall | 89,918 | 89,918 | 2002 | 164,507 |
| Genetic Medicine Building | 367,570 | 75,274 | 2008 | 239,781 |
| Marsico Hall | 351,885 | 75,302 | 2014 | 315,083 |
Asheville
Building |
Total (gsf) |
School Occupied (gsf) |
Year Completed |
| Karpen Hall | 64,000 | 7,918 | 1990 |
| Zeis Hall | 88,000 | 3,526 | 2008 |
gsf = gross square feet
*Data reflects total gross square feet only, not assigned department space
Fiscal Year |
Invention Disclosures |
U.S. Patents |
Startup Companies |
License Agreements |
| 2014 | 10 | 2 | 4 | 4 |
| 2013 | 16 | 2 | 2 | 2 |
| 2012 | 17 | 6 | 4 | 4 |
| 2011 | 19 | 19 | 4 | 5 |
| 2010 | 36 | 28 | 2 | 4 |
| 2009 | 21 | 21 | 2 | 9 |
| 2008 | 22 | 17 | 0 | 4 |
| 2007 | 8 | 10 | 0 | 0 |
| 2006 | 4 | 10 | 0 | 0 |
| 2005 | 8 | 16 | 0 | 1 |
| 2004 | 14 | 18 | 0 | 2 |
| 2003 | 3 | 16 | 2 | 11 |
Peer Institutions
Institutions selected in 2011 by the School’s Executive Committee as official peers for the UNC Eshelman School of Pharmacy. These peer institutions are used by the UNC Eshelman School of Pharmacy for various benchmarking purposes. They are considered “peers” of the UNC Eshelman School of Pharmacy in terms of mission; overall quality of faculty, students, and programs; and research productivity.
- University of Arizona
- University of California-San Francisco
- University of Florida
- University of Illinois-Chicago
- University of Kansas
- University of Kentucky
- University of Michigan-Ann Arbor
- University of Minnesota
- University of Texas-Austin
- University of Washington-Seattle
- University of Wisconsin-Madison
- Ohio State University